TABLE 3.
Case number | Age/sex | Type of vaccine | Dose after which adverse event was seen | Non‐local cutaneous reactions | Onset time of reaction | Localization | Other symptoms | Comorbidity |
---|---|---|---|---|---|---|---|---|
1 | 50s/F | CoronoVac | Second dose | Urticaria/angioedema | Day 5 | Face, trunk, back Extremities, neck Groin, axilla |
Fever, tachycardia Pruritus, dyspnea |
Diabetes hypertension Asthma |
2 | 60s/M | CoronoVac | Single dose | Ophthalmic herpes zoster | Day 17 | Face, scalp |
Fever Facial pain |
Hypertension |
3 | 20s/M | CoronoVac | Second dose | Pityriasis rosea | Day 7 | Trunk | None | None |
4 | 70s/M | CoronoVac | Second dose | AECD | Day 1 | Trunk, back Extremities, palm‐sole |
Pruritus Eosinophilia |
Hypertension |
5 | 60s/M | CoronoVac | First dose | Erythema multiforme | Day 10 |
Trunk, back Extremities |
Headache, fever Leukocytosis |
None |
6 | 70s/F | CoronoVac | First dose | Dyshidrotic eczema | Day 1 | Hands, feet | Burning, pruritus | Hypertension |
7 | 60s/F | CoronoVac | Second dose | Lichenoid reaction | Day 3 | Bilateral forearms | Pruritus | Endocrinological Disease, CAD |
8 | 60s/M | CoronoVac | Second dose | Leukocytoclastic vasculitis | Day 20 | Lower extremities |
Burning Pain in the legs |
None |
9 | 60s/F | CoronoVac | Both doses | Bullous pemphigoid | Day 10 | Trunk, back, extremities |
Pruritus, burning Eosinophilia |
Hypertension Bullous pemphigoid |
10 | 70s/M | CoronoVac | Second dose | Linear IgA bullous dermatosis | Day 30 | Trunk, neck, groin Axilla | Burning | Hypertension |
11 | 20s/F | BioNTech | Both doses | Urticaria/angioedema | Day 1 |
Face, trunk Extremities |
Pruritus, dyspnea Tachycardia Hypotension |
None |
12 | 30s/M | BioNTech | First dose | Herpes zoster | Day 17 | Genital, gluteal | Pain, anemia | Immunodeficiency |
13 | 40s/F | BioNTech | First dose | Maculopapular rash | Day 1 |
Trunk, back Extremities |
Pruritus, Eosinophilia | None |
14 | 30s/F | BioNTech | First dose | Herpes labialis | Day 5 | Lips | Fever, pain | None |
15 | 20s/M | BioNTech | First dose | Delayed large local reaction | Day 4 | Arm | Fever, pain | None |
16 | 50s/M | BioNTech | First dose | AECD | Day 14 | Face, trunk, back Extremities | Pruritus Eosinophilia | Diabetes, hypertension |
17 | 40s/M | BioNTech | First dose | Disseminated Herpes zoster | Day 14 |
Face, trunk, back Extremities |
Fever, headache nausea, vomiting meningeal irritation lymphopenia |
Kidney transplant (patient with immunodeficiency) |
18 | 60s/M | BioNTech | First dose | Erythroderma | Within 10 hours |
Face, groin, axilla Trunk, extremities Oral‐ genitalmucosa |
Fever Leukocytosis |
Hypertension, diabetes |
19 | 30s/F | BioNTech | First dose | Pityriasis rosea | Day 4 | Trunk and back | Fever, pruritus | None |
20 | 40s/M | BioNTech | First dose | Erythromelalgia | Day 14 |
Palm‐sole Urticarial lesions |
Pruritus | Cranial tumor |
Abbreviations: AECD, allergic eczematous contact dermatitis; CAD, coronary artery disease; F, female; M, male.